Classic view of this page
NGS Myeloid Panel
Clinical Genetic Test
Help
offered by
Alverno Laboratories
GTR Test Accession: Help GTR000597284.1
CAP
CANCERHEMATOLOGYIMMUNOLOGY ... View more
Last updated in GTR: 2021-12-28
View version history
Last annual review date for the lab: 2024-06-07 LinkOut
At a Glance
Test purpose: Help
Mutation Confirmation
Conditions (3): Help
Acute myeloid leukemia; Myelodysplastic syndrome; Myeloproliferative neoplasm
Genes (72): Help
ABL1 (9q34.12); ALK (2p23.2-23.1); ASXL1 (20q11.21); BAALC (8q22.3); BCL2 (18q21.33) more...
Methods (1): Help
Molecular Genetics - Targeted variant analysis: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Target population: Help
Not provided
Clinical validity: Help
Not provided
Clinical utility: Help
Not provided
Ordering Information
Offered by: Help
Alverno Laboratories
View lab's website
Manufacturer's name: Help
Oncomine Myeloid Assay
Specimen Source: Help
Who can order: Help
  • Health Care Provider
CPT codes: Help
**AMA CPT codes notice

Copyright: 2023 American Medical Association. All rights reserved.

Lab contact: Help
Gajendra Katara, PhD, HCLD(ABB), Lab Director
gajendra.katara@alvernolabs.com
+1-219-845-4314
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
Test development: Help
Manufactured (research use only; not FDA-reviewed)
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Test Order Code, How to Order, Test strategy
Conditions Help
Total conditions: 3
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 72
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Targeted variant analysis
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Mutation Confirmation
Recommended fields not provided:
Clinical validity, Clinical utility, Target population, What is the protocol for interpreting a variation as a VUS?, Are family members with defined clinical status recruited to assess significance of VUS without charge?, Will the lab re-contact the ordering physician if variant interpretation changes?, Is research allowed on the sample after clinical testing is complete?, Sample negative report, Sample positive report
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
Accuracy Correlation studies were performed comparing results of extracted DNA-only samples, RNA-only samples, peripheral blood samples, and bone marrow samples. Comprehensive positive controls were also used. Component SNP, MNP INDEL FLT3 ITD Fusion PPA (Sensitivity) 98.2% >99% >99% >99% Limit of Detection LOD was determined for each variant type (SNV/MNV, … View more
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
College of American Pathologists, CAP
Recommended fields not provided:
Test Confirmation, Assay limitations, Description of internal test validation method, Citations for Analytical validity, Description of PT method, Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.